The media database brings together all published information on platforms and products, as well as financial and corporate news.
Join our mailing list.
12/15/2015
Adocia to Hold Conference Call For Investors to Provide 2015 Annual Business Update and Perspectives For 2016
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
12/11/2015
Adocia and Lilly report positive results of a pilot bioequivalence study comparing BioChaperone Lispro U200 to BioChaperone Lispro U100
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
11/25/2015
Adocia announces positive Phase 1b results of BioChaperone® Combo in patients with type 2 diabetes
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
11/19/2015
Adocia receives the Deloitte In Extenso Technology Fast 50 Prize in the “Listed Company” category for the Grand Rhône-Alpes region
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
11/04/2015
Adocia announces positive Phase 1b results on the post-meal effect of BioChaperone® Combo in patients with type 1 diabetes
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
10/06/2015
Adocia and Lilly initiate a Phase 1b study evaluating ultra-rapid BioChaperone Lispro in patients with type 1 diabetes using insulin pump therapy
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
09/30/2015
Adocia and Lilly initiate a new Phase 1b study of repeat administration of ultra-rapid BioChaperone Lispro in patients with type 2 diabetes
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
08/27/2015
Adocia and Lilly initiate new Phase 1b study of repeated administration of ultra-rapid BioChaperone Lispro in patients with type 1 diabetes
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
07/10/2015
Adocia initiates two clinical studies on its combination of long-acting insulin glargine and fast-acting insulin lispro, BioChaperone® Combo
06/26/2015
Adocia and Lilly report positive Phase 1b topline results on the post-meal effect of ultra-rapid BioChaperone Lispro in patients with type 1 diabetes
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
06/05/2015
“Ultra-Rapid BioChaperone® Insulin Lispro (BC LIS): Linear Dose-Response and Faster Absorption than Insulin Lispro (LIS)” (Poster 979), presented by Dr. Grit Anderson, 75th Scientific Sessions of the American Diabetes Association, 5-9 June 2015, Boston, MA (USA)
05/28/2015
Adocia to Present Positive Clinical Results for BioChaperone® Lispro at the American Diabetes Association 75th Scientific Sessions on June 6th 2015
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
05/26/2015
Adocia to Present at the Jefferies 2015 Global Healthcare Conference in New-York City (USA)
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
05/04/2015
Adocia announces the release of its Reference Document, containing the Annual Financial Report, for the year 2014
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
03/16/2015
Adocia will present its 2014 annual results and its perspectives of growth during a conference call
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
03/05/2015
Adocia opens a subsidiary in the USA and is pleased to appoint Simon Bruce, MD and Stephen Daly
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
02/05/2015
Adocia reports positive results from phase IIa clinical study of fast-acting human insulin, HinsBet
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
01/20/2015
Adocia initiates a clinical study on the post-meal effect of ultra-rapid BioChaperone Lispro insulin formulation
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
12/19/2014
Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
09/30/2014
ADOCIA Wins Frost & Sullivan 2014 Technology Innovation Leadership Award in the Therapeutic Proteins Industry
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
09/09/2014
Adocia Reports Positive Preliminary Results from Dose Response Clinical Study of Ultra-fast acting BioChaperone® Lispro U100 in Patients with Type 1 Diabetes
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
07/09/2014
Adocia Announces Approval to Start a Phase IIa Clinical Study of HinsBet®, its Fast-acting Human Insulin, in Type 1 Diabetes
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
06/24/2014
ADA 74th Edition: Poster of positive results of Bio Chaperone® Lispro (english only)
06/16/2014
ADA 74th Edition: Poster of positive results of BioChaperone® Combo (english only)
06/13/2014
“Pharmacokinetic (PK) and Pharmacodynamic (PD) Characteristics of BioChaperone Combo (BC Combo), the First Fixed Combination of Glargine and Lispro, in Type 1 Diabetes”, (Poster 83-LB), presented by Dr. Ulrike Hövelmann, 74th Scientific Sessions American Diabetes Association 13-17 June 2014, San Francisco, CA, (USA)
06/13/2014
“The Ultra-Rapid BioChaperone® Insulin Lispro shows a Faster Onset of Action and Stronger Early Metabolic Effect than Native Insulin Lispro” (Poster 78-LB), presented by Dr. Grit Anderson, 74th Scientific Sessions of the American Diabetes Association, 13-17 June 2014, San Francisco, CA (USA)
06/10/2014
Adocia Announces Positive Preclinical Results for a Concentrated Ultra-Fast insulin, BioChaperone® Lispro U300
![Icon check](https://www.adocia.com/composants/themes/adocia/inc/assets/img/icon-download-blue.png)
06/04/2014
Adocia to Present Successful Clinical Results for BioChaperone® Lispro and BioChaperone® Combo at the American Diabetes Association 74th Scientific Sessions on June 15th 2014
03/26/2014
Gerard Soula Interview – La bourse et la vie (Transcript)
Join our mailing list. Subscribe